# Epidemiology & Cancer Control (ECC) Research Program

> **NIH CA P30** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2026 · $35,921

## Abstract

PROJECT SUMMARY/ABSTRACT 
The vision of the Epidemiology and Cancer Control Program (ECC) is to reduce the cancer burden in the 
PCC catchment area and beyond. To achieve this vision, we conduct innovative and high impact research, 
discovering risk factors and translating this knowledge into effective cancer control. Under the continued 
leadership of Jiyoung Ahn, PhD and new Co-Leader Danil Makarov, MD, MHS, ECC organizes its research 
efforts into four complementary thematic aims: Aim1: To discover and effectively modulate cancer-causing 
microbial and genetic risk factors, Aim 2: To assess and effectively control cancer-causing environmental and 
behavioral risk factors, and Aim 3: To improve cancer care delivery by identifying and disseminating best 
practices across the care continuum. The Program is composed of 37 full members from 15 academic 
departments in the NYU Grossman School of Medicine (NYUGSoM), particularly the Department of Population 
Health, as well as the NYU College of Nursing, College of Dentistry, and College of Global Public Health. ECC 
members currently have 76 funded projects totaling $13.1M in annual direct costs, $5.5M from NCI (43% of peer- 
reviewed funding). Our members are highly collaborative, as indicated by 34% intra- and 21% inter-programmatic 
collaborations, 52% inter-institutional collaborations (with other NCI-CCs), and 32 multi-PI grants. Program 
members published 858 papers in the current period, including many in top tier journals, such as NEJM, Lancet, 
and JAMA Pediatrics (19% of publications [n=163] have IF>10). Our signature research on the microbiome has 
led to novel discoveries of cancer-causing microbial risk factors, published in JAMA Oncology, Gut, JNCI and 
already cited more than 250 times; these paradigm-shifting hypotheses on microbial contribution to these 
malignancies have also fueled translation to clinical trials and stimulated new avenues of basic science research. 
Our work on developing innovative 

## Key facts

- **NIH application ID:** 11317121
- **Project number:** 5P30CA016087-45
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** Jiyoung  Ahn
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** CA
- **Fiscal year:** 2026
- **Award amount:** $35,921
- **Award type:** 5
- **Project period:** 1996-12-01T00:00:00 → 2029-02-28T00:00:00

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11317121

## Citation

> US National Institutes of Health, RePORTER application 11317121, Epidemiology & Cancer Control (ECC) Research Program (5P30CA016087-45). Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/grant/nih/11317121. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*